iSARP Clinical Trials
Enhancing clinical trial access for Alberta sarcoma patients remains a cornerstone of iSARP's mandate. Led by Drs. Khan and Feng, iSARP continues to see year-over-year expansion of clinical trials openings for sarcoma and related musculoskeletal neoplasms. iSARP also continues to strengthen its role within CanSaRCC, contributing high-quality clinical and outcomes data into this national sarcoma consortium.